Abstract
Bone scintigraphy is a sensitive technique to detect altered bone mineralization but has limited specificity. The use of SPECT/CT has improved significantly the diagnostic accuracy of bone scintigraphy, in patients with cancer as well as in evaluation of benign bone disease. It provides precise localization and characterization of tracer-avid foci, shortens the diagnostic workup, and decreases patient anxiety. Through both the SPECT and the CT components, SPECT/CT has an incremental value in characterizing benign bone lesions, specifically in the appendicular skeleton, as illustrated by present case series.
| Original language | English |
|---|---|
| Pages (from-to) | e195-e199 |
| Journal | Clinical Nuclear Medicine |
| Volume | 41 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2016 |
Bibliographical note
Publisher Copyright:Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Benign bone disease
- Bone scan
- SPECT/CT
Fingerprint
Dive into the research topics of 'Added value of SPECT/CT in the evaluation of benign bone diseases of the appendicular skeleton'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver